Colorectal cancer and potential predictors of never screened for faecal occult blood test: a narrative review

Abstract

Colorectal cancer (CRC) is a major public health threat. Therefore, CRC screening uptake has been a focus with the established precancerous lesion and the strong association of early detection with staging and survival of the disease. However, CRC screening is relatively low in many countries. This article briefly discussed the current situation of CRC, recommendations, and current uptake of CRC screening in various countries. Besides that, this article also highlights the potential factors that help to predict the CRC screening uptake worldwide. Identification of those factors could guide policymakers to develop an effective strategy to improve the CRC screening uptake and ultimately improve the health outcome of the population.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

International Agency for Research on Cancer, World health Organization. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Available from: https://www.iarc.who.int/featured-news/latest-global-cancer-data-cancer-burden-rises-to-18-1-million-new-cases-and-9-6-million-cancer-deaths-in-2018/

Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging vol. 2016;11:967. DOI: https://doi.org/10.2147/CIA.S109285

Lin SC, McKinley D, Sripipatana A, Makaroff L. Colorectal cancer screening at US community health centers: Examination of sociodemographic disparities and association with patient-provider communication. Cancer 2017;123:4185–92. DOI: https://doi.org/10.1002/cncr.30855

Brenner AT, Ko LK, Jans N, et al. Race/ethnicity and primary language: Health beliefs about colorectal cancer screening in a diverse, low-income population. J Health Care Poor Underserved 2015;26:824–38. DOI: https://doi.org/10.1353/hpu.2015.0075

Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082–91. DOI: https://doi.org/10.1111/j.1572-0241.2003.07574.x

Harada K, Lee S, Shimada H, et al. Distance to screening site and older adults’ participation in cognitive impairment screening. Geriatr Gerontol Int 201;18:146-53. DOI: https://doi.org/10.1111/ggi.13133

Bernardo BM, Gross AL, Young G, et al. Predictors of colorectal cancer screening in two underserved U.S. populations: A parallel analysis. Front Oncol 2018;8:230. DOI: https://doi.org/10.3389/fonc.2018.00230

Rosli MAF, Az-Zaharaa WKW, Suresh F, et al. Knowledge and attitude on colorectal cancer screening among sub-urban community in Sepang, Sealangor. Int J Public Health Clin Sci 2017;4:85–101.

Christou A, Thompson SC. Colorectal cancer screening knowledge, attitudes and behavioural intention among Indigenous Western Australians. BMC Public Health 2012;12:528. DOI: https://doi.org/10.1186/1471-2458-12-528

Su TT, Goh JY, Tan J, et al. Level of colorectal cancer awareness: A cross sectional exploratory study among multi-ethnic rural population in Malaysia. BMC Cancer 2013;13:376. DOI: https://doi.org/10.1186/1471-2407-13-376

Douma LN, Uiters E, Timmermans DRM. Why are the public so positive about colorectal cancer screening? BMC Public Health 2018;18:1212. DOI: https://doi.org/10.1186/s12889-018-6106-1

Sung JJY, Choi SYP, Chan FKL, et al. Obstacles to colorectal cancer screening in Chinese: A study based on the Health Belief Model. Am J Gastroenterol 2008;103:974–81. DOI: https://doi.org/10.1111/j.1572-0241.2007.01649.x

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. DOI: https://doi.org/10.3322/caac.21492

Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683–91. DOI: https://doi.org/10.1136/gutjnl-2015-310912

Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. Dis Colon Rectum 2010;53:1099.

Ministry of Health of Malaysia. Malaysia National Cancer Registry Report 2012-2016. National Cancer Registry, NCI. Publication No. 5. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Laporan/Umum/2012-2016%20(MNCRR)/MNCR_2012-2016_FINAL_(PUBLISHED_2019).pdf

Ab Azizah M, Nor Saleha IT, Noor Hashimah A, et al. Malaysian National Cancer Registry Report 2007-2011. Ministry of Health of Malaysia. Available from: https://www.crc.gov.my/wp-content/uploads/documents/report/MNCRRrepor2007-2011.pdf

Shah SA, Neoh H-M, Abdul Rahim SSS, et al. Spatial analysis of colorectal cancer cases in Kuala Lumpur. Asian Pac J Cancer Prev 2014;15:1149-54. DOI: https://doi.org/10.7314/APJCP.2014.15.3.1149

Valan A, Najid F, Chandran P, et al. Distinctive clinico-pathological characteristics of colorectal cancer in Sabahan indigenous populations. Asian Pacific J Cancer Prev 2021;22:749–55. DOI: https://doi.org/10.31557/APJCP.2021.22.3.749

Winawer SJ. Natural history of colorectal cancer. Am J Med 1999;106:S3-6. DOI: https://doi.org/10.1016/S0002-9343(98)00338-6

Risio M. The natural history of adenomas. Best Pract Res Clin Gastroenterol 2010;24:271-80. DOI: https://doi.org/10.1016/j.bpg.2010.04.005

Ijspeert JEG, Vermeulen L, Meijer GA, Dekker E. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol 2015;12:401–9. DOI: https://doi.org/10.1038/nrgastro.2015.73

Jun TY, Tan W, Jinyu C. Detection rate of colonic polyp among patients who had undergone colonoscopy at gastroenterology unit of Serdang Hospital, Malaysia. Med J Malaysia 2019;74;20–4.

Dembert ML, Brownstein AH, Keith JF. Principles and practices of screening for disease. Mil Med 1988;153:16–20. DOI: https://doi.org/10.1093/milmed/153.1.16

US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315:2564–75. DOI: https://doi.org/10.1001/jama.2016.5989

Rhodes JM. Colorectal cancer screening in the UK: Joint position statement by the British Society of Gastroenterology, the Royal College of Physicians, and the Association of Coloproctology of Great Britain and Ireland. Gut 2000;46:746-8. DOI: https://doi.org/10.1136/gut.46.6.746

Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001;165:206-8.

Sung JJY, Lau JYW, Youg GP, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008;57:1166–76. DOI: https://doi.org/10.1136/gut.2007.146316

Demers RY, Stawick LE, Demers P. Relative sensitivity of the fecal occult blood test and flexible sigmoidoscopy in detecting polyps. Prev Med 1985;14:55–62. DOI: https://doi.org/10.1016/0091-7435(85)90020-9

Lieberman D, Weiss D. One-time screening for colorectal cancer with combined fecal. N Engl J Med 2001;345:555–60. DOI: https://doi.org/10.1056/NEJMoa010328

Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: A retrospective cohort study. Ann Intern Med 2016;64:456–63. DOI: https://doi.org/10.7326/M15-0983

Lee KJ, Inoue M, Otani T, et al. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: A prospective cohort study in Japan. Cancer Detect Prev 2007;31:3–11. DOI: https://doi.org/10.1016/j.cdp.2006.11.002

Ministry of Health of Malaysia. [Panduan untuk program saringan kanser kolorektal (Guidelines for colorectal cancer screening programs)].[in Malaysian]. Ministry of Health of Malaysia; 2015. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Rujukan/NCD/Kanser/FA_BOOKLET_FINAL.pdf

Vieth M, Quirke P, Lambert R, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition -- Annotations of colorectal lesions. Endoscopy 2012;44:SE131-9. DOI: https://doi.org/10.1055/s-0032-1309798

American Cancer Society. Colorectal Cancer Facts & Figures 2017-2019. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf

Vinker S, Nakar S, Rosenberg E, Kitai E. The role of family physicians in increasing annual fecal occult blood test screening coverage: A prospective intervention study. Isr Med Assoc J 2002;4:424–5.

Tinmouth J, et al. Increasing participation in colorectal cancer screening: Results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders. Int J Cancer 2015;136:e697-703. DOI: https://doi.org/10.1002/ijc.29191

Zarychanski R, Chen Y, Bernstein CN, Hébert PC. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ 2007;177:593-7. DOI: https://doi.org/10.1503/cmaj.070558

National Cancer Center, Center for Cancer Control and Information Services. Cancer Screening Program. Tokyo: National Cancer Center. Available from: https://www.ncc.go.jp/en/index.html

Choi KS, Lee HY, Jun JK, et al. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol 2012;27:1070–7. DOI: https://doi.org/10.1111/j.1440-1746.2011.06944.x

Khuhaprema T, Sangrajrang S, Lalitwongsa S,et al. Organised colorectal cancer screening in Lampang Province, Thailand: Preliminary results from a pilot implementation programme. BMJ Open 2014;4:e003671. DOI: https://doi.org/10.1136/bmjopen-2013-003671

Chiu H-M, Chen Sl-S, Yen, AM-F, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 2015;121:3221–9. DOI: https://doi.org/10.1002/cncr.29462

Sazali MF, Rahim SSA, Avoi R, et al., Factors of never screened with faecal occult blood test in public primary care facilities. Asian Pacific J Cancer Prev 2021;22:163–9. DOI: https://doi.org/10.31557/APJCP.2021.22.1.163

Yusoff HM, Daud N, Noor NM, Rahim AA. Participation and barriers to colorectal cancer screening in Malaysia. Asian Pacific J Cancer Prev 2012;13:3983–7. DOI: https://doi.org/10.7314/APJCP.2012.13.8.3983

Koo JH, Leong RWL, Chung J, et al., Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: A multicenter study. Gastrointest Endosc 2012;76:126–35. DOI: https://doi.org/10.1016/j.gie.2012.03.168

Jeffree MS, Ahmedy F, Avoi R, et al. Integrating digital health for healthcare transformation: Conceptual model of smart healthcare for northern Borneo. Int J Adv Trends Comput Sci Eng 2020;9:17912020. DOI: https://doi.org/10.30534/ijatcse/2020/17912020

Lo SH, Waller J, Vrinten C, et al. Social cognitive mediators of sociodemographic differences in colorectal cancer screening uptake. Biomed Res Int 2015;2015:165074. DOI: https://doi.org/10.1155/2015/165074

Klabunde CN, Zheng Y, Quinn VP, et al. Influence of age and comorbidity on colorectal cancer screening in the elderly. Am J Prev Med 2016;51:67–75. DOI: https://doi.org/10.1016/j.amepre.2016.04.018

Moss S, Mathews C, Day DJ, et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: Results from a pilot study within the national screening programme in England. Gut 2017;66:1631–44. DOI: https://doi.org/10.1136/gutjnl-2015-310691

Guiriguet C, Pera G, Castells A, et al. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: A cross-sectional study. BMC Cancer 2017;17:524. DOI: https://doi.org/10.1186/s12885-017-3516-x

Clarke N, Sharp L, Osborne A, Kearney PM. Comparison of uptake of colorectal cancer screening based on fecal immunochemical testing (FIT) in males and females: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2015;24:39–47. DOI: https://doi.org/10.1158/1055-9965.EPI-14-0774

Mehta SJ, Jensen CD, Quinn VP, et al. Race/ethnicity and adoption of a population health management approach to colorectal cancer screening in a community-based healthcare system. J Gen Intern Med 2016;31:1323–30. DOI: https://doi.org/10.1007/s11606-016-3803-2

Ho C, Kornfield R, Vittinghoff E, et al. Late presentation of colorectal cancer in a vulnerable population. Am J Gastroenterol 2013;108:466–70. DOI: https://doi.org/10.1038/ajg.2012.256

El-Haddad B, Dong F, Kallai KJl, et al. Association of marital status and colorectal cancer screening participation in the USA. Colorectal Dis 2015;17:O108–14. DOI: https://doi.org/10.1111/codi.12926

Hanske J, Meyer CP, Sammon JD, et al. The influence of marital status on the use of breast, cervical, and colorectal cancer screening. Prev Med 2016;89:140–5. DOI: https://doi.org/10.1016/j.ypmed.2016.05.017

Van Jaarsveld CHM, Miles A, Edwards R, Wardle J. Marriage and cancer prevention: Does marital status and inviting both spouses together influence colorectal cancer screening participation? J Med Screen 2006;13:172–6. DOI: https://doi.org/10.1177/096914130601300403

Berkowitz SA, Percac-Lima S, Ashburner JM, et al. Building equity improvement into quality improvement: reducing socioeconomic disparities in colorectal cancer screening as part of population health management. J Gen Intern Med 2015;30:942–9. DOI: https://doi.org/10.1007/s11606-015-3227-4

Calo WA, Vernon SW, Lairson DR, Linder SH. Associations between contextual factors and colorectal cancer screening in a racially and ethnically diverse population in Texas. Cancer Epidemiol 2015;39:798–804. DOI: https://doi.org/10.1016/j.canep.2015.09.012

Suh M, Choi KS, Lee H-Y, et al. Socioeconomic disparities in colorectal cancer screening in Korea a nationwide cross-sectional study. Medicine (Baltimore) 2015;94:e1368. DOI: https://doi.org/10.1097/MD.0000000000001368

Frederiksen BL, Jørgensen T, Brasso K, et al. Socioeconomic position and participation in colorectal cancer screening. Br J Cancer 2010;103:1496–501. DOI: https://doi.org/10.1038/sj.bjc.6605962

Deding U, Henig AS, Salling A, et al. Sociodemographic predictors of participation in colorectal cancer screening. Int J Colorectal Dis 2017;32:1117-24. DOI: https://doi.org/10.1007/s00384-017-2832-6

Burgard SA, Brand JE, House JS. Perceived job insecurity and worker health in the United States. Soc Sci Med 2009;69:777–85. DOI: https://doi.org/10.1016/j.socscimed.2009.06.029

Juon HS, Han W, Shin H, et al. Predictors of older Korean Americans’ participation in colorectal cancer screening. J Cancer Educ 2003;18;37–42. DOI: https://doi.org/10.1207/S15430154JCE1801_13

von Wagner C, Cadar D, Hackett RA, et al. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. J Med Screen 2020;27:25-30. DOI: https://doi.org/10.1177/0969141319874834

Rocque GB, Williams CP, Miller HD, et al. Impact of travel time on healthcare costs and resource utilization by phase of care for older cancer patients. J Clin Oncol 2019;37:1935-45. DOI: https://doi.org/10.1200/JCO.2019.37.15_suppl.6560

Kelly C, Hulme C, Farragher T, Clarke G. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open 2016;6:e013059. DOI: https://doi.org/10.1136/bmjopen-2016-013059

Yong SK, Ong WS, Koh GCH, et al. Colorectal cancer screening: Barriers to the faecal occult blood test (FOBT) and colonoscopy in Singapore. Proc Singapore Healthcare 2016;25:207–14. DOI: https://doi.org/10.1177/2010105816643554

Guerra CE, Schwartz JS, Armstrong K, et al. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med 2007;22:1681–8. DOI: https://doi.org/10.1007/s11606-007-0396-9

Tessaro I, Mangone C, ParkarI, Pawar V. Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev Chronic Dis 2006;3:A123.

Harmy MY, Norwati D, Noor NM, Amry AR. Knowledge and attitude of colorectal cancer screening among moderate risk patients in West Malaysia. Asian Pacific J Cancer Prev 2011;12:1957–60.

Post DM, Katz ML, Tatum C, et al. Determinants of colorectal cancer screening in primary care. J Cancer Educ 2008;23:241–7. DOI: https://doi.org/10.1080/08858190802189089

Scottish Government Social Research Group. Guide 4: Understanding and measuring attitudes. Scottish Government; 2007. Available from: https://www.gov.scot/binaries/content/documents/govscot/publications/advice-and-guidance/2009/12/social-research-methods-guides/documents/measuring-and-understanding-attitudes/measuring-and-understanding-attitudes/govscot%3Adocument/Measuring%2Band%2BUnderstanding%2BAttitudes.pdf

Cullati S, Charvet-Bérard AI, Perneger TV. Cancer screening in a middle-aged general population: Factors associated with practices and attitudes. BMC Public Health 2009;9:118. DOI: https://doi.org/10.1186/1471-2458-9-118

Published
2021-08-04
Info
Issue
Section
Reviews
Keywords:
Colorectal cancer, screening uptake, predictors, barriers for screening
Statistics
  • Abstract views: 314

  • PDF: 94
How to Cite
Sazali, M. F., Rahim, S. S. S. A., Hayati, F., Mohd Daud, M. N., Avoi, R., Omar, A., Atil, A., Abd Rahim, M. A., Madrim, M. F., Mokti, K., Ramdzan, A. R., Sidek Ahmad, Z. N., Zakaria, A. D., Che Ani, M. F., Ibrahim, A. F., Azhar, Z. I., Jeffree, M. S., & Hassan, M. R. (2021). Colorectal cancer and potential predictors of never screened for faecal occult blood test: a narrative review. Journal of Public Health Research. https://doi.org/10.4081/jphr.2021.2377

Most read articles by the same author(s)